Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I Single and Multiple-Dose Safety and Pharmacokinetic Clinical S-261025118
University of Pennsylvania IN
Search grants from University of Pennsylvania IN
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Cognitive impairment in Mexican Americans: a population-based study
Structural bases for cellular stress responses mediated by stalled translation
Immunogenicity of Listeria-derived antigens
Immunoregulation of Herpes Encephalitis By Microglia
Grants for Graduate Training in Family Medicine
Recently added grants:
Treating hyperexcitability in Alzheimers disease with levetiracetam to improve brain function and cognition
Deciphering molecular mechanisms that underlie brain endothelial cell dysfunction with APOE4
First-in-human SAD & MAD trials for MW151, a novel Alzheimer's disease drug candidate that attenuates proinflammatory cytokine dysregulation
Immunoglobulins Delivered by AVV Vector for the Prevention of SIV Infection
Mechanisms That Control Antigen Receptor Variable Region Exon Assembly
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN025118-003
Application #
7191428
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2005
Total Cost
Indirect Cost
Institution
Name
University of Pennsylvania IN
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2005
N01 CN
Phase I Single and Multiple-Dose Safety and Pharmacokinetic Clinical S-261025118
/ University of Pennsylvania IN
NIH 2004
N01 CN
Phase I Single and Multiple-Dose Safety and Pharmacokinetic Clinical S-261025118
/ University of Pennsylvania IN
Comments
Be the first to comment on this grant